You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Human Papillomavirus

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Serum Galectin-3 as a Marker of Human Papillomavirus Infection

Completed
  • Human Papillomavirus Infection
  • cryotherapy
  • serum Galectin-3 assay
  • Assiut, Egypt
    Assiut University
Aug 17, 2023

Women's Values in Managing Human Papillomavirus (HPV)

Not yet recruiting
  • Human Papilloma Virus Infection
  • No intervention
  • (no location specified)
Nov 6, 2023

Human Papillomavirus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

Completed
  • Human Papillomavirus Infection
  • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
  • Recombinant nonavalent Human Papillomavirus (Types 6,11,16,18,31,33,45,52,58) Vaccine
  • Nanjing, Jiangsu, China
    CDC, Jiangsu Province
Jan 12, 2023

Human Papillomavirus Infection Trial in United States (Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant

Active, not recruiting
  • Human Papillomavirus Infection
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +5 more
Jan 26, 2023

Human Papillomavirus-Related Carcinoma Trial in Seattle (Discussion, Educational Activity, Healthcare Activity)

Recruiting
  • Human Papillomavirus-Related Carcinoma
  • Discussion
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Apr 26, 2023

Warts Trial in Salt Lake City (Human Papillomavirus 9-valent Vaccine, Recombinant, Normal Saline)

Not yet recruiting
  • Warts
  • Human Papillomavirus 9-valent Vaccine, Recombinant
  • Normal Saline
  • Salt Lake City, Utah
  • +1 more
Nov 23, 2022

Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC

Recruiting
  • Head and Neck Carcinoma
  • Adult Disease
  • HPVDC injection level dose 1
  • +3 more
  • Villejuif, France
    Gustave Roussy
Aug 17, 2023

Cervical Carcinoma, Human Papillomavirus Infection Trial in Liberia (Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis

Enrolling by invitation
  • Cervical Carcinoma
  • Human Papillomavirus Infection
  • Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
  • +3 more
  • Liberia, Guanacaste, Costa Rica
    Agencia Costarricense de Investigaciones Biomédicas - Fundación
Aug 11, 2022

Human Papilloma Virus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

Completed
  • Human Papilloma Virus Infection
  • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
  • Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)
  • Nanjing, Jiangsu, China
    CDC, Jiangsu Province
Jan 12, 2023

Human Papillomavirus (HPV)-Related Malignancies, Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies

Completed
Has Results
  • Human Papillomavirus (HPV)-Related Malignancies
  • Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
  • Basking Ridge, New Jersey
  • +5 more
Dec 14, 2022

HPV Associated Cancers Trial in New York, Houston (TGN-S11, Pembrolizumab)

Not yet recruiting
  • HPV Associated Cancers
  • New York, New York
  • +1 more
Apr 25, 2023

Human Papillomavirus in Young People Epidemiological Research 4

Not yet recruiting
  • Human Papillomavirus Infection
  • +6 more
    • (no location specified)
    Oct 17, 2022

    Human Papillomavirus in Young People Epidemiological Research 3

    Not yet recruiting
    • Human Papillomavirus Infection
    • +6 more
      • (no location specified)
      Oct 17, 2022

      Verruca Plantaris Trial in Surrey (Sterile water foot bath, Nitric Oxide)

      Not yet recruiting
      • Verruca Plantaris
      • Sterile water foot bath
      • Nitric Oxide
      • Surrey, British Columbia, Canada
        Achilles Foot Health Centre
      May 26, 2023

      Human Papillomavirus Infection Trial in Guangzhou, Nanjing, Taiyuan (Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58)

      Active, not recruiting
      • Human Papillomavirus Infection
      • Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
      • Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)（GARDASIL®）
      • Guangzhou, Guangdong, China
      • +2 more
      Dec 30, 2022

      Human Papillomavirus Infection Trial in Canberra (Human papillomavirus (HPV) Vaccine, Placebo)

      Not yet recruiting
      • Human Papillomavirus Infection
      • Human papillomavirus (HPV) Vaccine
      • Placebo
      • Canberra, Australia
        Paratus Clinical Research Canberra
      Jan 4, 2023

      Human Papillomavirus-Related Carcinoma Trial in Columbus (Educational Intervention, Informational Intervention, Survey

      Recruiting
      • Human Papillomavirus-Related Carcinoma
      • Educational Intervention
      • +2 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      May 9, 2022

      Global Burden Estimation of Human Papillomavirus (GLOBE-HPV)

      Not yet recruiting
      • HPV Infection
      • Urine Sample Collection
      • +2 more
      • Dhaka, Bangladesh
      • +7 more
      Nov 10, 2023

      HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Orange (Intensity-Modulated Radiation Therapy (IMRT))

      Recruiting
      • HPV Positive Oropharyngeal Squamous Cell Carcinoma
      • Intensity-Modulated Radiation Therapy (IMRT)
      • Orange, California
        Chao Family Comprehensive Cancer Center, University of Californi
      Nov 4, 2022

      Human Papillomavirus Vaccine Trial in Banjul (9-valent human papillomavirus vaccine (Gardasil 9) - 3 doses, 9-valent human

      Active, not recruiting
      • Human Papillomavirus Vaccine
      • 9-valent human papillomavirus vaccine (Gardasil 9) - 3 doses
      • +2 more
      • Banjul, Outside U.S. And Canada, Gambia
        Ed Clarke
      Mar 15, 2022

      Human Papillomavirus-Related Carcinoma Trial in Austria, United States (procedure, biological, other)

      Not yet recruiting
      • Human Papillomavirus-Related Carcinoma
      • Biospecimen Collection
      • +4 more
      • Birmingham, Alabama
      • +4 more
      Aug 9, 2023

      Longitudinal HPV Pap in CIN and VAIN

      Recruiting
      • Cervical Intraepithelial Neoplasia
      • +3 more
      • HPV test and Pap Smear
      • Taoyuan City, Taiwan
        Chang Gung Medical Foundation
      Jun 27, 2023

      Individuals Who Have Experienced Sexual Trauma

      Not yet recruiting
      • Cervical Carcinoma
      • Human Papillomavirus Infection
      • HPV Self-Collection
      • +2 more
      • Portland, Oregon
        OHSU Knight Cancer Institute
      Jul 12, 2022

      Idiopathic CD4 T Cell Lymphocytopenia Trial run by the NIAID (Gardasil 9)

      Recruiting
      • Idiopathic CD4 T Cell Lymphocytopenia
      • Gardasil 9
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 10, 2023

      Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematopoietic and Lymphoid Cell Tumor Trial in Houston (Recombinant

      Active, not recruiting
      • Allogeneic Hematopoietic Stem Cell Transplant Recipient
      • Hematopoietic and Lymphoid Cell Neoplasm
      • Recombinant Human Papillomavirus Nonavalent Vaccine
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 29, 2022